نتایج جستجو برای: intrahepatic immunopathophysiology

تعداد نتایج: 11631  

Journal: : 2021

Intrahepatic cholestasis of pregnancy is the most common pregnancy-related liver disease that occurs during pregnancy. It causes mortality and morbidity. In this review, intrahepatic (ICP) discussed with current literature.

Journal: :Journal of pediatric surgery 2002
Yoshiaki Tsuchida Atsushi Takahashi Norio Suzuki Minoru Kuroiwa Hideaki Murai Fumiaki Toki Hideo Kawarasaki Kohei Hashizume Toshiro Honna

BACKGROUND The incidence of intrahepatic cholelithiasis and cholangitis has not yet been well studied postoperatively in patients with choledochal cysts. METHODS One hundred three patients with choledochal cysts had operative cholangiography, underwent standard excision of a choledochal cyst with Roux-en-Y hepatico-jejunal anastomosis, and were at a mean follow-up of 12 1/2 years. The inciden...

Journal: :Annals of the National Academy of Medical Sciences (India) 2020

Journal: :middle east journal of digestive diseases 0
mohammadhadi imanieh seyedmohsen dehghani maryam khoshkhui abdorrasoul malekpour

background all conditions that interfere with blood flow at any level within the portal system can lead to portal hypertension. for better management of this disorder, it is important to determine the underlying cause. in previ­ous studies, extra-hepatic disorders have been reported as the main cause of portal hypertension in children. in this study, we investigate the under­lying causes of por...

Journal: :acta medica iranica 0
kavehmanesh z kosari f

this report presents an 11 year-old girl with benign recurrent cholestasis (bric) who developed episodes of severe jaundice and pruritus at the ages of 2.5 and 10 years. each episode lasted for 3-4 months. the peak level of serum bilirubin reached 33-37 mg/dl.liver function tests were all normal during the attack except for increased alkaline phosphatase and prolonged prothrombin time responsiv...

Journal: :The Keio journal of medicine 2004
Makoto Chuma Norihisa Saeki Yoshiya Yamamoto Tsutomu Ohta Masahiro Asaka Setsuo Hirohashi Michiie Sakamoto

Hepatocellular carcinoma (HCC) is one of the most common and aggressive human malignancies. Its high mortality rate is mainly a result of intra-hepatic metastases. To investigate the detailed genetic mechanisms in cancer metastasis, we compared the expression profiles of 20 HCCs with intrahepatic metastasis and 10 HCCs without intrahepatic metastasis using an oligonucleotide array. Of the appro...

2016
Dhaval Gupta Nirav Pipaliya Nilesh Pandav Kaivan Shah Meghraj Ingle Prabha Sawant

Intrahepatic pseudocyst is a very rare complication of pancreatitis. Lack of experience and literature makes diagnosis and management of intrahepatic pseudocyst very difficult. Majority of published cases were managed by either percutaneous or surgical drainage. Less than 30 cases of intrahepatic pseudocysts have been reported in the literature and there is not a single report of endoscopic ult...

Journal: :گوارش 0
marziye ghalamkari internal medicine resident at imam khomeini hospital,tums mahdi khatuni researcher, department of internal medicine, imam khomeini hospital,tehran university of medical sciences, tehran, iran mohammad taher fellowship of gastroenterology, imam khomeini hospital,tehran university of medical sciences, tehran, iran mahmood khaniki assistant professor, department of pathology, imam khomeini hospital,tehran university of medical sciences, tehran, iran

despite the fact that hepatic involvement is frequently seen in systemic primary amyloidosis, major hepatic symptoms as primary manifestation and severe impaired liver function are rare. herein, we report a 38-year-old woman with primary hepatic amyloidosis, and severe  portal hypertension . the patient had ascites and markedly elevated alkaline phosphatase level at presentation. she had a rapi...

2017
Narges Dargahi Maria Katsara Theodore Tselios Maria-Eleni Androutsou Maximilian de Courten John Matsoukas Vasso Apostolopoulos

The treatment of multiple sclerosis (MS) has changed over the last 20 years. All immunotherapeutic drugs target relapsing remitting MS (RRMS) and it still remains a medical challenge in MS to develop a treatment for progressive forms. The most common injectable disease-modifying therapies in RRMS include β-interferons 1a or 1b and glatiramer acetate. However, one of the major challenges of inje...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید